IVVD Q1 2022 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena

IVVDInvivyd, Inc.

$257M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$101M

Net Income

-$101M

EPS (Diluted)

$-0.93

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$59M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$556M

Total Liabilities

$97M

Stockholders' Equity

$459M

Cash & Equivalents

$532M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$101M	-$39M	-160.2%
Net Income	-$101M	-$39M	-160.1%